SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-000995
Filing Date
2015-02-20
Accepted
2015-02-20 15:18:31
Documents
16
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223058z10-k.htm 10-K 2341491
2 EX-12 a2223058zex-12.htm EX-12 21295
3 EX-21 a2223058zex-21.htm EX-21 179351
4 EX-23.1 a2223058zex-23_1.htm EX-23.1 3940
5 EX-23.2 a2223058zex-23_2.htm EX-23.2 3511
6 EX-31.1 a2223058zex-31_1.htm EX-31.1 7732
7 EX-31.2 a2223058zex-31_2.htm EX-31.2 7723
8 EX-32.1 a2223058zex-32_1.htm EX-32.1 4720
9 EX-32.2 a2223058zex-32_2.htm EX-32.2 4712
16 G111602.JPG g111602.jpg GRAPHIC 59339
  Complete submission text file 0001047469-15-000995.txt   26520268

Data Files

Seq Description Document Type Size
10 EX-101.INS abbv-20141231.xml EX-101.INS 5793638
11 EX-101.SCH abbv-20141231.xsd EX-101.SCH 80919
12 EX-101.CAL abbv-20141231_cal.xml EX-101.CAL 106505
13 EX-101.DEF abbv-20141231_def.xml EX-101.DEF 420271
14 EX-101.LAB abbv-20141231_lab.xml EX-101.LAB 966012
15 EX-101.PRE abbv-20141231_pre.xml EX-101.PRE 668175
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35565 | Film No.: 15635334
SIC: 2834 Pharmaceutical Preparations